C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/06 (2006.01) A61K 31/495 (2006.01) B28B 1/40 (2006.01) B28B 21/48 (2006.01) C07C 271/22 (2006.01) C07C 279/24 (2006.01) C07C 323/44 (2006.01)
Patent
CA 2121609
- 81 - Abstract of Disclosure: A tricyclic quinoxalinedione derivative represented by the formula 1: Image wherein X represents hydrogen, alkyl, halogen, cyano, trifluoromethyl, or nitro; R1 represents hydrogen, alkyl, cycloalkyl, or cycloalkylalkyl; G represents -CONR2- or -NR2CO-, wherein R2 represents hydrogen or alkyl; J represents an acidic group or a group which is convertible thereto in vivo; E represents an basic group or a group which is convertible thereto in vivo; Y represents a single bond, alkylene, alkenylene, substituted alkylene, or Y1-Q-Y2, wherein Y1 represents a single bond or alkylene, Y2 represents alkylene, and Q represents a heteroatom selected from oxygen or sulfur; Z represents alkylene. or a pharmaceutically acceptable salt thereof, these compounds are selective antagonists of glycine binding site of the NMDA receptor.
Ae Nobuyuki
Kodo Toru
Nagata Ryu
Tanno Norihiko
Yamaguchi Hiroshi
Kirby Eades Gale Baker
Sumitomo Pharmaceuticals Company Limited
LandOfFree
Tricyclic quinoxalinedione derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic quinoxalinedione derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic quinoxalinedione derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1364664